Sheldon L. Koenig

CIK 1766524 · President and CEO · last filed 2026-03-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.84M

Companies

2

Total Filings

28

Lifetime Open-Market Net

-$450.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ESPR President and CEO 2,172,699 $3.15 $6.84M -$450.0K 23 2026-03-18
PORTOLA PHARMACEUTICALS INC (PTLA) Delisted EVP, Chief Commercial Officer 0 $0 5 2020-07-02

Recent Filings · Page 3 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-11-01 ESPR Grant (A) +26,700 $0 EDGAR
2021-05-18 ESPR Grant (A) +20,000 $0 EDGAR
2021-01-29 ESPR Grant (A) +30,000 $0 EDGAR
2020-07-02 PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Mixed −5,075 -$96.1K EDGAR
2020-03-03 PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Tax (F) −4,327 -$41.9K EDGAR
2020-02-26 PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Grant (A) $0 EDGAR
2020-02-04 PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Grant (A) +16,250 $0 EDGAR
2019-02-04 PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Grant (A) +25,000 $0 EDGAR
Showing 2128 of 28
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.